![](/img/cover-not-exists.png)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, Farbod, Wu, Xiumin, Malik, Ajay K, Zhong, Cuiling, Baldwin, Megan E, Schanz, Stefanie, Fuh, Germaine, Gerber, Hans-Peter, Ferrara, NapoleoneVolume:
25
Year:
2007
Language:
english
Pages:
10
DOI:
10.1038/nbt1323
File:
PDF, 383 KB
english, 2007